Pan Jay, Qin Xuezheng, Hsieh Chee-Ruey
1West China School of Public Health,Sichuan University,Sichuan,China.
3School of Economics,Peking University,Beijing,China.
Health Econ Policy Law. 2016 Oct;11(4):337-57. doi: 10.1017/S1744133116000220. Epub 2016 Jun 27.
The new round of health care reforms in China achieved significant initial results. New and emerging problems coinciding with the deepening of the reforms, however, require further institutional changes to strengthen the competition mechanism and promote public hospital efficiency. This paper provides a conceptual framework and preliminary assessment of public hospital competition in China. Specifically, we distinguish between two closely related concepts - competition and privatization, and identify several critical conditions under which hospital competition can be used as a policy instrument to improve health care delivery in China. We also investigate the current performance and identify several unintended consequences of public hospital competition - mainly, medical arms race, drug over-prescription and the erosion of a trusting relationship between patients and physicians. Finally, we discuss the policy options for enhancing the internal competition in China's hospital market, and conclude that public investment on information provision is key to reaping the positive outcomes of pro-competition policies.
中国新一轮医疗改革取得了显著的初步成效。然而,随着改革的深入,新出现的问题需要进一步的制度变革,以强化竞争机制并提高公立医院效率。本文提供了一个关于中国公立医院竞争的概念框架和初步评估。具体而言,我们区分了两个密切相关的概念——竞争和私有化,并确定了几个关键条件,在这些条件下,医院竞争可作为一种政策工具,用以改善中国的医疗服务。我们还研究了当前的绩效,并确定了公立医院竞争的一些意外后果——主要是医疗军备竞赛、药物过度处方以及医患信任关系的削弱。最后,我们讨论了增强中国医院市场内部竞争的政策选择,并得出结论,对信息提供进行公共投资是收获促进竞争政策积极成果的关键。